NHL reporter Jessi Pierce and her 3 children dead after fatal fire
01:01
Trump admin. to send ICE agents to assist TSA at airports
02:17
Person of interest in custody in connection to student’s killing
01:19
Higher oil prices from war with Iran threaten global economy
00:57
Iran unswayed by Trump's 48-hour deadline and threats to 'obliterate' energy infrastructure
02:37
Meteor spotted streaking above Texas
01:15
Good News: Basketball coach with rare eye condition inspires players
01:31
Historic flood emergency prompts mass rescues in Hawaii
02:15
Guthrie family thanks Tucson, asks people to not forget mother's case
01:40
Major flood emergency prompts mass evacuations and rescues in Hawaii
01:51
Nuclear sites targeted across Middle East amid war with Iran
02:38
U.S. ramps up pressure on Cuba as Trump considers possible action
01:54
Good News: Officer’s daughter shows him out of service with final call
02:50
Robert Mueller, former special counsel who led Trump-Russia probe, dies at 81
02:06
Trump admin. rushes to contain rising oil and gas prices amid Iran war
01:42
Trump threatens to send ICE agents to airports amid TSA travel chaos
02:07
Markets drop as gas prices, mortgage rates rise
00:53
Cost of war in Iran hits America’s heartland
02:31
Strike hits Jerusalem’s Old City
02:01
Trump weighs deploying ground troops
01:45
Nightly News
A new gene therapy could be a game-changer for patients with severe anemia. The cost? $2.8 million.
NBC News Clone summarizes the latest on: A New Gene Therapy Could Be A Game Changer For Patients With Severe Anemia The Cost 2 8 Million 158699589511 - Breaking News | NBC News Clone. This article is rewritten and presented in a simplified tone for a better reader experience.
02:52
Copied
A new gene therapy called Zynteglo could eliminate iron-rich blood transfusions used to treat patients with beta thalassemia that causes severe anemia but it costs around $2.8 million. NBC News’ Anne Thompson shares more details about the gene therapy’s price and why the experts say it’s only a sign of things to come.Dec. 24, 2022
